<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="publisher-id">JOACP</journal-id><journal-title-group><journal-title>Journal of Anaesthesiology, Clinical Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0970-9185</issn><issn pub-type="epub">2231-2730</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24106359</article-id><article-id pub-id-type="pmc">3788233</article-id><article-id pub-id-type="publisher-id">JOACP-29-342</article-id><article-id pub-id-type="doi">10.4103/0970-9185.117101</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Intravenous dexmedetomidine versus clonidine for prolongation of bupivacaine spinal anesthesia and analgesia: A randomized double-blind study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Reddy</surname><given-names>Velayudha Sidda</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Shaik</surname><given-names>Nawaz Ahmed</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Donthu</surname><given-names>Balaji</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Reddy Sannala</surname><given-names>Venkata Krishna</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Jangam</surname><given-names>Venkatsiva</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Department of Anesthesiology and Critical Care, Rajiv Gandhi Institute of Medical Sciences, Kadapa, Andhra Pradesh, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Velayudha S Reddy, Department of Anaesthesiology, Rajiv Gandhi Institute of Medical Sciences, Kadapa - 517 502, Andhra Pradesh, India. E-mail: <email xlink:href="drvelayudhareddy@yahoo.co.in">drvelayudhareddy@yahoo.co.in</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2013</year></pub-date><volume>29</volume><issue>3</issue><fpage>342</fpage><lpage>347</lpage><permissions><copyright-statement>Copyright: &#x000a9; Journal of Anaesthesiology Clinical Pharmacology</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Alpha<sub>2</sub>-adrenergic agonists have synergistic action with local anesthetics and may prolong the duration of sensory, motor blockade and postoperative analgesia obtained with spinal anesthesia.</p></sec><sec id="st2"><title>Aim:</title><p>The objectives of this study are to compare and evaluate the efficacy of intravenous dexmedetomidine premedication with clonidine and placebo on spinal blockade duration, postoperative analgesia and sedation in patients undergoing surgery under bupivacaine intrathecal block.</p></sec><sec id="st3"><title>Materials and Methods:</title><p>In this prospective, randomized, double-blind placebo-controlled study, 75 patients of the American Society of Anesthesiologists status I or II, scheduled for orthopedic lower limb surgery under spinal anesthesia, were randomly allocated into three groups of 25 each. Group DE received dexmedetomidine 0.5 &#x003bc;gkg<sup>&#x02212;1</sup>, group CL received clonidine 1.0 &#x003bc;gkg<sup>&#x02212;1</sup> and placebo group PL received 10 ml of normal saline intravenously before subarachnoid anesthesia with 15 mg of 0.5% hyperbaric bupivacaine. Onset time and regression times of sensory and motor blockade, the maximum upper level of sensory blockade were recorded. Duration of postoperative analgesia and sedation scores along with side effects were also recorded. Data was analyzed using analysis of variance or Chi-square test, and the value of <italic>P</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec><sec id="st4"><title>Results:</title><p>The sensory block level was higher with dexmedetomidine (T4 &#x000b1; 1) than clonidine (T6 &#x000b1; 1) or placebo (T6 &#x000b1; 2). Dexmedetomidine also increased the time (243.35 &#x000b1; 56.82 min) to first postoperative analgesic request compared with clonidine (190.93 &#x000b1; 42.38 min, <italic>P</italic> &#x0003c; 0.0001) and placebo (140.75 &#x000b1; 28.52 min, <italic>P</italic> &#x0003c; 0.0001). The maximum Ramsay sedation score was greater in the dexmedetomidine group than other two groups (<italic>P</italic> &#x0003c; 0.0001).</p></sec><sec id="st5"><title>Conclusion:</title><p>Premedication with intravenous dexmedetomidine is better than intravenous clonidine to provide intraoperative sedation and postoperative analgesia during bupivacaine spinal anesthesia.</p></sec></abstract><kwd-group><kwd>Clonidine</kwd><kwd>dexmedetomidine</kwd><kwd>intravenous</kwd><kwd>postoperative analgesia</kwd><kwd>premedication</kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title>Introduction</title><p>Many techniques and drug regimens, with partial or greater success, have been tried from time to time to eliminate the anxiety component and to prolong the postoperative analgesia during regional anesthesia.[<xref ref-type="bibr" rid="ref1">1</xref><xref ref-type="bibr" rid="ref2">2</xref>] Alpha<sub>2</sub>-adrenergic agonists have both analgesic and sedative properties, when used as an adjuvant to regional anesthesia.[<xref ref-type="bibr" rid="ref3">3</xref><xref ref-type="bibr" rid="ref4">4</xref>] They potentiate the effect of local anesthetics and prolong the duration of both motor, sensory spinal blockade and postoperative analgesia.[<xref ref-type="bibr" rid="ref5">5</xref><xref ref-type="bibr" rid="ref6">6</xref><xref ref-type="bibr" rid="ref7">7</xref>] Clonidine is a partial &#x003b1;<sub>2</sub>-adrenoreceptor agonist used intrathecally, with a well-established record of efficacy and safety.[<xref ref-type="bibr" rid="ref6">6</xref>]</p><p>Dexmedetomidine is a selective &#x003b1;<sub>2</sub>-adrenoreceptor agonist; it has a &#x003b1;<sub>2</sub>/&#x003b1;<sub>1</sub> selectivity ratio which is eight to 10 times higher than that of clonidine.[<xref ref-type="bibr" rid="ref8">8</xref>] Analgesic and sedative properties were found when intrathecal, epidural or intravenous dexmedetomidine was used as an adjuvant in previous studies.[<xref ref-type="bibr" rid="ref9">9</xref><xref ref-type="bibr" rid="ref10">10</xref><xref ref-type="bibr" rid="ref11">11</xref><xref ref-type="bibr" rid="ref12">12</xref><xref ref-type="bibr" rid="ref13">13</xref><xref ref-type="bibr" rid="ref14">14</xref>] There is paucity of studies which have compared the dose equivalence of these two drugs, however various studies have established that the dose of clonidine is 1.5-2 times higher than the dose of dexmedetomidine.[<xref ref-type="bibr" rid="ref15">15</xref><xref ref-type="bibr" rid="ref16">16</xref><xref ref-type="bibr" rid="ref17">17</xref><xref ref-type="bibr" rid="ref18">18</xref>]</p><p>We designed a prospective, randomized, double-blind, placebo-controlled clinical study, to evaluate and compare the efficacy of intravenous dexmedetomidine with clonidine and placebo on spinal blockade duration, postoperative analgesia and sedation as premedication to intrathecal bupivacaine.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><p>After approval of the study protocol by our institutional ethics committee, written informed consent was obtained from each patient. Seventy-five ASA status I and II patients, of either sex, aged 40-60 years, weighing 50-70 kgs, measuring 150-170 cm height, with 20-25 kg/m<sup>2</sup> of body mass index (BMI), undergoing orthopedic lower limb surgery under spinal anesthesia were enrolled in the present study. Patients with a history of alcohol or drug abuse, diabetes mellitus, cardiac disease, hypertension, chronic obstructive respiratory disease, psychological disease, hepatic and/or renal disease, spinal deformities or any contraindication to spinal anesthesia (for e.g., coagulation defects, infection at the puncture site, pre-existing neurological deficits in the body, etc.) and patients allergic to amide type of local anesthetics were excluded from the study.</p><p>On arrival to the operation theater, following insertion of an 18-G venous cannula, all patients received 500 ml of Ringer's lactate solution before spinal anesthesia. Standard monitors like electrocardiography (ECG), non-invasive blood pressure (NIBP) and pulse oximetry (SpO<sub>2</sub>) were attached and the baseline parameters were recorded. Using a computer-generated randomization schedule, the patients were randomly divided into three groups, group DE (<italic>n</italic> = 25) received dexmedetomidine 0.5 &#x003bc;gkg<sup>-1</sup>; group CL (<italic>n</italic> = 25) received clonidine 1.0 &#x003bc;gkg<sup>-1</sup> and group PL (placebo, <italic>n</italic> = 25) received 10 ml of physiological saline, before spinal anesthesia. The study drugs were premixed to a total volume of 10 ml and were administered intravenously over a period of 10 min as a single dose by an anesthesiologist not involved in the study. Five minutes after the end of the infusion, with the patients in the sitting position, lumbar puncture was performed at L<sub>3</sub>-L<sub>4</sub> spinal interspace through a standard midline approach using a 25-G Quincke spinal needle. Hyperbaric, 0.5% bupivacaine 15 mg was injected intrathecally, and all patients received oxygen 5 Lmin<sup>-1</sup> via a face mask throughout the procedure after approximating them to the surgical position. The patient and the anesthesiologist were blinded to the treatment group, and all recordings were performed by an anesthesiologist blinded to group allocation. Sensory blockade was assessed using sterile pin prick method in the mid-axillary line on both sides of chest. Immediately after sensory block assessment, motor block was assessed using a modified Bromage scale[<xref ref-type="bibr" rid="ref19">19</xref>] (grade 0: No paralysis; 1: Unable to raise extended leg; 2: Unable to flex knee; 3: Unable to flex ankle).</p><p>Sensory and motor block was assessed every minute for the first 10 minutes (mins) and thereafter every 10 mins during surgery and every 15 mins, postoperatively. Onset times of both sensory and motor blockade were assessed and recorded. The highest dermatomal level of sensory blockade and recovery times of both sensory and motor blockade was recorded. Recovery time for the sensory blockade was defined as two-dermatome regression of anesthesia from the maximum level. Motor block duration was the time to return to grade-1 on the modified Bromage scale. Postoperative pain was assessed by using the visual analog scale,[<xref ref-type="bibr" rid="ref20">20</xref>] (VAS; 0: No pain; 10: Worst possible pain) at 4, 8, 12 and 24 hr. Patients with a VAS score of 3 or more received injection Diclofenac sodium 75-mg intramuscularly. The time of first request for postoperative analgesia after surgery was recorded as duration of postoperative analgesia.</p><p>The Ramsay sedation score, was used to assess sedation (1: Anxious or agitated; 2: Co-operative and tranquil; 3: Drowsy but responsive to command; 4: Asleep but responsive to glabellar tap; 5: Asleep with a sluggish response to tactile stimulation; and 6: Asleep and no response). The score was re-evaluated every 10 min after administration of drug for up to 180 min and every 15 min thereafter. Excessive sedation was defined as a sedation score which was greater than four (5/6).</p><p>The anesthesiologist who performed the block recorded the vital data, heart rate (HR), mean arterial pressure (MAP), oxygen saturation (SpO<sub>2</sub>), respiratory rate (RR) before premedication, 2 min after end of premedication, immediately before and 60 seconds after dural puncture, every 5 min after spinal anesthesia during surgery and every 15 minutes in the postoperative ward until a complete reversal of spinal block. Hypotension (defined by a decrease in MAP below 20% of baseline or systolic pressure &#x0003c;90 mmHg) was treated with incremental doses of mephenteramine 3.0 mg i.v., and additional lactated Ringer's solution as appropriate. Bradycardia (HR&#x0003c; 50 beats/min) was treated with atropine 0.5 mg i.v., to avoid masking of respiratory depression by administering supplemental oxygen, respiratory depression was defined as a respiratory rate &#x0003c;12 breaths min<sup>-1</sup>.</p><sec id="sec2-1"><title>Statistical analysis</title><p>Sample size calculation was based on a previous study,[<xref ref-type="bibr" rid="ref15">15</xref>] for which we assumed a standard deviation (SD) of 24 min in time to sensory regression of two dermatomes, an &#x003b1;-error of 0.05, and a &#x003b2;-error of 0.2. To show a 20% difference in sensory regression of two dermatomes, at least 23 patients per group were needed, so we selected 25 patients per group. The data were analyzed statistically using Graph Pad prism 5.02 version, parametric testing was done using one-way analysis of variance (ANOVA), intergroup comparison was done with Tukey-Kramer multiple comparison (TKMC) test and categorical data were analyzed using the Chi-square test. Data was presented as mean &#x000b1; SD or number of patients (percentage) per category. The values of <italic>P</italic> &#x0003c; 0.05 were considered to indicate statistical significance.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p>Spinal anesthesia was successful in all the patients and all the 75 patients completed the study. The demographic profiles of the patients among the groups were comparable with regards to age, weight and body mass index. The distribution of vital data and mean duration of surgery was comparable among the groups [<xref ref-type="table" rid="T1">Table 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Patient's characteristics and preoperative vital data</p></caption><graphic xlink:href="JOACP-29-342-g001"/></table-wrap><p>Intravenous dexmedetomidine premedication during bupivacaine spinal anesthesia resulted in early onset of sensory block to T<sub>10</sub> level (2.91 &#x000b1; 1.16 min) as compared to clonidine (3.58 &#x000b1; 1.06 min) and achieved maximum upper level of sensory block (T4 &#x000b1; 1) which is higher than clonidine (T6 &#x000b1; 1) or placebo (T6 &#x000b1; 2). Time of onset of motor block was reduced by dexmedetomidine (3.64 &#x000b1; 0.75 min) but not by clonidine (4.21 &#x000b1; 1.49 min) when compared with placebo (4.57 &#x000b1; 0.83 min). Time for sensory regression of two dermatomes was 148.54 &#x000b1; 20.66 mins in the dexmedetomidine group which was longer than the clonidine (126.38 &#x000b1; 16.04 min) or the placebo (95.38 &#x000b1; 17.41 min) groups. Dexmedetomidine also increased the time to first request for postoperative analgesia (243.35 &#x000b1; 56.82 min) compared with clonidine (190.93 &#x000b1; 42.38 min) and placebo (140.75 &#x000b1; 28.52 min). Duration of motor block was not significantly prolonged by either of the drugs [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Highest sensory level, sensory and motor regression times and postoperative analgesia</p></caption><graphic xlink:href="JOACP-29-342-g002"/></table-wrap><p>When we observed the trend of mean HR [<xref ref-type="fig" rid="F1">Figure 1</xref>], heart rates in the dexmedetomidine group appears to be lower than that of clonidine and placebo groups, but there is no statistically significant difference among the groups except at 5 mins after spinal anesthesia where the mean heart rate was significantly lower (<italic>P</italic> = 0.0299). Mean heart rates of both the groups were above 70/min indicating the hemodynamic stability in dexmedetomidine and clonidine groups at given doses.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Comparison of heart rate in the PL, DE and CL groups, covering the pre-, intra- and post-operative period</p></caption><graphic xlink:href="JOACP-29-342-g003"/></fig><p>The trend of MAP [<xref ref-type="fig" rid="F2">Figure 2</xref>], in our observation showed no significant difference in MAP among the groups before administration of premedication but both dexmedetomidine and clonidine group had a significantly lower MAP after premedication, up to 5 mins after spinal anesthesia when compared to saline group (ANOVA values of P: After premedication <italic>P</italic> = 0.0347, before spinal <italic>P</italic> = 0.0055, 2 mins after spinal <italic>P</italic> = 0.0292 and 5 minutes after spinal <italic>P</italic> = 0.0418). Dexmedetomidine and clonidine group do not differ significantly after premedication but after 2 mins and 5 mins of administration of spinal anesthesia, MAP was lower in the dexmedetomidine group (<italic>P</italic> &#x0003c; 0.05 by TKMC-test). Perioperative MAP was above 75 mm of Hg among the groups, at all times, indicating the hemodynamic stability in dexmedetomidine and clonidine groups at given doses.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Comparison of mean arterial pressure (MAP) in the group PL, DE and CL covering the pre-, intra- and post-operative period</p></caption><graphic xlink:href="JOACP-29-342-g004"/></fig><p>Mean sedation scores were significantly higher in the dexmedetomidine group (<italic>P</italic> &#x0003c; 0.0001). Patients with sedation scores greater than three were 68% in dexmedetomidine group, 24% in clonidine group and 12% in the placebo group. Bradycardia, hypotension, nausea and vomiting were not statistically significant among the groups [<xref ref-type="table" rid="T3">Table 3</xref>].</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Adverse events</p></caption><graphic xlink:href="JOACP-29-342-g005"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>Dexmedetomidine and clonidine, have been used as adjuvants to local anesthetics by intrathecal, epidural, caudal, intravenous routes and for peripheral nerve blocks.[<xref ref-type="bibr" rid="ref10">10</xref><xref ref-type="bibr" rid="ref11">11</xref><xref ref-type="bibr" rid="ref12">12</xref><xref ref-type="bibr" rid="ref13">13</xref><xref ref-type="bibr" rid="ref14">14</xref>] Dexmedetomidine is a highly selective &#x003b1;<sub>2</sub>-adrenoreceptor agonist with &#x003b1;<sub>2</sub>:&#x003b1;<sub>1</sub> binding ratio of 1620:1 compared to 220:1 for clonidine.[<xref ref-type="bibr" rid="ref20">20</xref><xref ref-type="bibr" rid="ref21">21</xref>]</p><p>Dexmedetomidine has been used intravenously in doses ranging from 0.1 to 10 &#x003bc;g/kg/h but higher doses have been associated with a significant incidence of bradycardia and hypotension.[<xref ref-type="bibr" rid="ref22">22</xref><xref ref-type="bibr" rid="ref23">23</xref>] Aantaa <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref24">24</xref>] concluded that &#x0201c;The optimal dose of dexmedetomidine for single dose intravenous premedication in minor surgery appears to be in the range of 0.33 to 0.67 &#x003bc;g/kg. Jaakola <italic>et al</italic>.,[<xref ref-type="bibr" rid="ref25">25</xref>] demonstrated moderate analgesia with a ceiling effect at a dose of 0.5 &#x003bc;gkg<sup>&#x02212;1</sup>. Thus we selected a dose of 0.5 &#x003bc;gkg<sup>-1</sup> as premedication in our study. As rapid administration of dexmedetomidine might produce tachycardia, bradycardia and hypertension,[<xref ref-type="bibr" rid="ref26">26</xref>] we administered dexmedetomidine, 0.5 &#x003bc;gkg<sup>-1</sup> slowly, over a period of 10 min in our study. Previous studies have elucidated a dose of clonidine, which is 1.5-2 times higher than the dose of dexmedetomidine.[<xref ref-type="bibr" rid="ref15">15</xref><xref ref-type="bibr" rid="ref27">27</xref>] Based on the observations of previous studies[<xref ref-type="bibr" rid="ref15">15</xref><xref ref-type="bibr" rid="ref26">26</xref>] a dose of 1.0&#x003bc;gkg<sup>-1</sup> of clonidine was selected in our study.</p><p>In our study, both dexmedetomidine and clonidine reduced the onset times of sensory and motor block, and prolonged the duration of sensory blockade. However the duration of motor blockade was not prolonged. Similar results have been observed by Fatma Nur Kaya <italic>et al</italic>.[<xref ref-type="bibr" rid="ref28">28</xref>] The analgesia produced by &#x003b1;<sub>2</sub>-agonist is due to their action at spinal, supra-spinal, direct analgesic and/or vasoconstricting actions on blood vessels.[<xref ref-type="bibr" rid="ref29">29</xref>] The locus ceruleus and the dorsal raphe nucleus are the important central neural structures where these drugs act to produce sedation and analgesia.[<xref ref-type="bibr" rid="ref22">22</xref>] This supra-spinal action could explain the prolongation of spinal anesthesia after intravenous administration of dexmedetomidine and clonidine.</p><p>In our study, two-segment regression time of sensory block and time of first request for analgesic were significantly prolonged in the dexmedetomidine group than clonidine and placebo groups. This could be attributed to the mechanism of action of dexmedetomidine which differs from clonidine in being eight to ten times more selective to &#x003b1;<sub>2</sub>-adrenoceptors especially for &#x003b1;<sub>2A</sub> and &#x003b1;<sub>2C</sub> subtype of this receptor.[<xref ref-type="bibr" rid="ref22">22</xref>] Time for regression of motor block did not differ among the groups. The mechanism of motor block produced by &#x003b1;<sub>2</sub>-agonist is unclear but there is some evidence that clonidine results in direct inhibition of impulse conduction in the large, myelinated A-&#x003b1; fibers. The 50% effective concentration (EC50%) measured to block motor fibers is approximately 4-folds that of small, unmyelinated C fibers.[<xref ref-type="bibr" rid="ref30">30</xref>] This could explain the less prolonged motor block compared with sensory block, as conduction of motor nerve fibers were less inhibited than sensory nerve fibers at the same concentration of clonidine. A similar mechanism can explain the prolongation of sensory block as compared with the motor block in the dexmedetomidine group.</p><p>Hemodynamic parameters, both HR and MAP were stable during perioperative period and the fall in HR and MAP were less than 20% from baseline among the groups. The incidence of hypotension and bradycardia were more in the dexmedetomidine group but not statistically significant. These hemodynamic changes were due to decrease in central sympathetic outflow.</p><p>The sedation produced by dexmedetomidine differs from other sedatives, as patients may be easily aroused and remain co-operative.[<xref ref-type="bibr" rid="ref31">31</xref>] In our study, excessive sedation was observed in two patients of the dexmedetomidine group compared with no patient in the clonidine and placebo group. Studies report minimal to none respiratory depression following dexmedetomidine administration,[<xref ref-type="bibr" rid="ref32">32</xref>] which has also been validated by the results of our study.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusions</title><p>Single dose of intravenous dexmedetomidine resulted in an early onset action of bupivacaine, rapid establishment of both sensory and motor blockade, prolonged duration of analgesia into the postoperative period and stable cardiovascular parameters thereby making dexmedetomidine an effective adjuvant than clonidine for bupivacaine spinal anesthesia.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hohener</surname><given-names>D</given-names></name><name><surname>Blumenthal</surname><given-names>S</given-names></name><name><surname>Borgeat</surname><given-names>A</given-names></name></person-group><article-title>Sedation and regional anaesthesia in the adult patient</article-title><source>Br J Anaesth</source><year>2008</year><volume>100</volume><fpage>8</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">18070783</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helgeson</surname><given-names>LE</given-names></name></person-group><article-title>Sedation during regional anaesthesia: Inhalational versus intravenous</article-title><source>Curr Opin Anaesthesiol</source><year>2005</year><volume>18</volume><fpage>534</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16534289</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabriel</surname><given-names>JS</given-names></name><name><surname>Gordin</surname><given-names>V</given-names></name></person-group><article-title>Alpha 2 agonists in regional anaesthesia and analgesia</article-title><source>Curr Opin Anaesthesiol</source><year>2001</year><volume>14</volume><fpage>751</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">17019175</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauro</surname><given-names>VA</given-names></name><name><surname>Brand&#x000e3;o</surname><given-names>ST</given-names></name></person-group><article-title>Clonidine and dexmedetomidine through epidural route for post-operative analgesia and sedation in a cholecystectomy</article-title><source>Rev Bras Anestesiol</source><year>2004</year><volume>4</volume><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strebel</surname><given-names>S</given-names></name><name><surname>Gurzeler</surname><given-names>JA</given-names></name><name><surname>Schneider</surname><given-names>MC</given-names></name><name><surname>Aeschbach</surname><given-names>A</given-names></name><name><surname>Kindler</surname><given-names>CH</given-names></name></person-group><article-title>Small-dose intrathecal clonidine and isobaric bupivacaine for orthopedic surgery: A dose-response-study</article-title><source>Anesth Analg</source><year>2004</year><volume>99</volume><fpage>1231</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15385382</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobrydnjov</surname><given-names>I</given-names></name><name><surname>Axelsson</surname><given-names>K</given-names></name><name><surname>Thorn</surname><given-names>SE</given-names></name><name><surname>Matthiesen</surname><given-names>P</given-names></name><name><surname>Klockhoff</surname><given-names>H</given-names></name><name><surname>Holmstorm</surname><given-names>B</given-names></name><etal/></person-group><article-title>Clonidine combined with small-dose bupivacaine during spinal anesthesia for inguinal herniorrhaphy: A randomized double-blinded study</article-title><source>Anesth Analg</source><year>2003</year><volume>96</volume><fpage>1496</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">12707157</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sethi</surname><given-names>BS</given-names></name><name><surname>Samuel</surname><given-names>M</given-names></name><name><surname>Sreevastava</surname><given-names>D</given-names></name></person-group><article-title>Efficacy of analgesic effects of low dose intrathecal clonidine as adjuvant to bupivacaine</article-title><source>Indian J Anaesth</source><year>2007</year><volume>51</volume><fpage>415</fpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coursin</surname><given-names>DB</given-names></name><name><surname>Maccioli</surname><given-names>GA</given-names></name></person-group><article-title>Dexmedetomidine</article-title><source>Curr Opin Crit Care</source><year>2001</year><volume>7</volume><fpage>221</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11571417</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshitomi</surname><given-names>T</given-names></name><name><surname>Kohjitani</surname><given-names>A</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name><name><surname>Higuchi</surname><given-names>H</given-names></name><name><surname>Shimada</surname><given-names>M</given-names></name><name><surname>Miyawaki</surname><given-names>T</given-names></name></person-group><article-title>Dexmedetomidine enhances the local anesthetic action of lidocaine via an alpha-2A adrenoceptor</article-title><source>Anesth Analg</source><year>2008</year><volume>107</volume><fpage>96</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">18635472</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Hennawy</surname><given-names>AM</given-names></name><name><surname>Abd-Elwahab</surname><given-names>AM</given-names></name><name><surname>Abd-Elmaksoud</surname><given-names>AM</given-names></name><name><surname>El-Ozairy</surname><given-names>HS</given-names></name><name><surname>Boulis</surname><given-names>SR</given-names></name></person-group><article-title>Addition of clonidine or dexmedetomidine to bupivacaine prolongs caudal analgesia in children</article-title><source>Br J Anaesth</source><year>2009</year><volume>103</volume><fpage>268</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">19541679</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanazi</surname><given-names>GE</given-names></name><name><surname>Aouad</surname><given-names>MT</given-names></name><name><surname>Jabbour-Khoury</surname><given-names>SI</given-names></name><name><surname>Al Jazzar</surname><given-names>MD</given-names></name><name><surname>Alameddine</surname><given-names>MM</given-names></name><name><surname>Al-Yaman</surname><given-names>R</given-names></name><etal/></person-group><article-title>Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block</article-title><source>Acta Anaesthesiol Scand</source><year>2006</year><volume>50</volume><fpage>222</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16430546</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neogi</surname><given-names>M</given-names></name><name><surname>Bhattacharjee</surname><given-names>DP</given-names></name><name><surname>Dawn</surname><given-names>S</given-names></name><name><surname>Chatterjee</surname><given-names>N</given-names></name></person-group><article-title>A comparative study between clonidine and dexmedetomidine used as adjuncts to ropivacaine for caudal analgesia in paediatric patients</article-title><source>J Anaesthesiol Clin Pharmacol</source><year>2010</year><volume>26</volume><fpage>149</fpage><lpage>53</lpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>CK</given-names></name><name><surname>Ray</surname><given-names>M</given-names></name><name><surname>Sen</surname><given-names>A</given-names></name><name><surname>Hajra</surname><given-names>B</given-names></name><name><surname>Mukherjee</surname><given-names>D</given-names></name><name><surname>Ghanta</surname><given-names>AK</given-names></name></person-group><article-title>Changes in intraocular pressure following administration of suxamethonium and endotracheal intubation: Influence of dexmedetomidine premedication</article-title><source>Indian J Anaesth</source><year>2011</year><volume>55</volume><fpage>573</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22223900</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konakci</surname><given-names>S</given-names></name><name><surname>Adanir</surname><given-names>T</given-names></name><name><surname>Yilmaz</surname><given-names>G</given-names></name><name><surname>Rezanko</surname><given-names>T</given-names></name></person-group><article-title>The efficacy and neurotoxicity of dexmedetomidine administered via the epidural route</article-title><source>Eur J Anaesthesiol</source><year>2008</year><volume>25</volume><fpage>403</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18088445</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajwa</surname><given-names>SJ</given-names></name><name><surname>Bajwa</surname><given-names>SK</given-names></name><name><surname>Kaur</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>G</given-names></name><name><surname>Arora</surname><given-names>V</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><etal/></person-group><article-title>Dexmedetomidine and clonidine in epidural anesthesia: A comparative evaluation</article-title><source>Indian J Anaesth</source><year>2011</year><volume>55</volume><fpage>116</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">21712865</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>RN</given-names></name><name><surname>Nascimento</surname><given-names>JP</given-names></name></person-group><article-title>The use of dexmedetomidine in anesthesiology</article-title><source>Rev Bras Anestesiol</source><year>2003</year><volume>53</volume><fpage>97</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">19475263</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LindeH</surname><given-names>e Mo</given-names></name></person-group><article-title>The clinical use of dexmedetomidine</article-title><source>Rev Bras Anestesiol</source><year>2004</year><volume>54</volume><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnaider</surname><given-names>TB</given-names></name><name><surname>Vieira</surname><given-names>AM</given-names></name><name><surname>Brand&#x000e3;o</surname><given-names>AC</given-names></name><name><surname>Lobo</surname><given-names>MV</given-names></name></person-group><article-title>Intra-operative analgesic effect of cetamine, clonidine and dexmedetomidine, administered through epidural route in surgery of the upper abdomen</article-title><source>Rev Bras Anestesiol</source><year>2005</year><volume>55</volume><fpage>525</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">19468643</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korula</surname><given-names>S</given-names></name><name><surname>George</surname><given-names>GM</given-names></name><name><surname>Ipe</surname><given-names>S</given-names></name><name><surname>Abraham</surname><given-names>SP</given-names></name></person-group><article-title>Epidural anesthesia and post-operative analgesia for bilateral inguinal mesh hernioplasty: Comparison of equipotent doses of ropivacaine and bupivacaine</article-title><source>Saudi J Anaesth</source><year>2011</year><volume>5</volume><fpage>277</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">21957406</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wewers</surname><given-names>ME</given-names></name><name><surname>Lowe</surname><given-names>NK</given-names></name></person-group><article-title>A clinical review of Visual analogue scale in the measurement of clinical phenomena</article-title><source>Res Nurs Health</source><year>1990</year><volume>13</volume><fpage>227</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">2197679</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grewal</surname><given-names>A</given-names></name></person-group><article-title>Dexmedetomidine: New avenues</article-title><source>J Anaesthesiol Clin Pharmacol</source><year>2011</year><volume>27</volume><fpage>297</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">21897496</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feld</surname><given-names>JM</given-names></name><name><surname>Hoffman</surname><given-names>WE</given-names></name><name><surname>Stechert</surname><given-names>MM</given-names></name><name><surname>Hoffman</surname><given-names>IW</given-names></name><name><surname>Ananda</surname><given-names>RC</given-names></name></person-group><article-title>Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery</article-title><source>J Clin Anesth</source><year>2006</year><volume>18</volume><fpage>24</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16517328</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramsey</surname><given-names>MA</given-names></name><name><surname>Saha</surname><given-names>D</given-names></name><name><surname>Hebeler</surname><given-names>RF</given-names></name></person-group><article-title>Tracheal resection in the morbidly obese patient: The role of dexmedetomidine</article-title><source>J Clin Anesth</source><year>2006</year><volume>18</volume><fpage>452</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">16980164</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aantaa</surname><given-names>RE</given-names></name><name><surname>Unto</surname><given-names>JH</given-names></name><name><surname>Scheinin</surname><given-names>M</given-names></name><name><surname>Kallio</surname><given-names>AM</given-names></name><name><surname>Scheinin</surname><given-names>H</given-names></name></person-group><article-title>Dexmedetomidine premedication for minor gynecologic surgery</article-title><source>Anesth Analg</source><year>1990</year><volume>70</volume><fpage>407</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">1969252</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaakola</surname><given-names>ML</given-names></name><name><surname>Salonen</surname><given-names>M</given-names></name><name><surname>Lehtinen</surname><given-names>R</given-names></name><name><surname>Scheinin</surname><given-names>H</given-names></name></person-group><article-title>The analgesic action of dexmedetomidine-a novel &#x003b1;<sub>2</sub>-adrenoceptor agonist-in healthy volunteers</article-title><source>Pain</source><year>1991</year><volume>46</volume><fpage>281</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">1684653</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>SA</given-names></name><name><surname>Breslin</surname><given-names>DS</given-names></name><name><surname>MacLeod</surname><given-names>DB</given-names></name><name><surname>Gleason</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>G</given-names></name></person-group><article-title>Dexmedetomidine infusion for sedation during fiberoptic intubation: A report of three cases</article-title><source>J Clin Anesth</source><year>2004</year><volume>16</volume><fpage>124</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15110375</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaabachi</surname><given-names>O</given-names></name><name><surname>Zarghouni</surname><given-names>A</given-names></name><name><surname>Ouezini</surname><given-names>R</given-names></name><name><surname>Abdelaziz</surname><given-names>AB</given-names></name><name><surname>Chattaoui</surname><given-names>O</given-names></name><name><surname>Kokki</surname><given-names>H</given-names></name></person-group><article-title>Clonidine 1&#x003bc;g/kg is a safe and effective adjuvant to plain bupivacaine in spinal anesthesia in adolescents</article-title><source>Anesth Analg</source><year>2007</year><volume>105</volume><fpage>516</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17646515</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaya</surname><given-names>FN</given-names></name><name><surname>Yavascaoglu</surname><given-names>B</given-names></name><name><surname>Turker</surname><given-names>G</given-names></name><name><surname>Yildirim</surname><given-names>A</given-names></name><name><surname>Gurbet</surname><given-names>A</given-names></name><name><surname>Mogol</surname><given-names>EB</given-names></name><etal/></person-group><article-title>Intravenous dexmedetomidine, but not midazolam, prolongs bupivacaine spinal anesthesia</article-title><source>Can J Anaesth</source><year>2010</year><volume>57</volume><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">20039221</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebert</surname><given-names>TJ</given-names></name><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Barney</surname><given-names>JA</given-names></name><name><surname>Uhrich</surname><given-names>TD</given-names></name><name><surname>Colinco</surname><given-names>MD</given-names></name></person-group><article-title>The effects of increasing plasma concentrations of dexmedetomidine in humans</article-title><source>Anesthesiology</source><year>2000</year><volume>93</volume><fpage>382</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">10910487</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Metwalli</surname><given-names>RR</given-names></name><name><surname>Mowafi</surname><given-names>HA</given-names></name><name><surname>Ismail</surname><given-names>SA</given-names></name><name><surname>Siddiqui</surname><given-names>AK</given-names></name><name><surname>Al-Ghamdi</surname><given-names>AM</given-names></name><name><surname>Shafi</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Effect of intra-articular dexmedetomidine on postoperative analgesia after arthroscopic knee surgery</article-title><source>Br J Anaesth</source><year>2008</year><volume>101</volume><fpage>395</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18567675</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ustun</surname><given-names>Y</given-names></name><name><surname>Gunduz</surname><given-names>M</given-names></name><name><surname>Erdogan</surname><given-names>O</given-names></name><name><surname>Benlidayi</surname><given-names>ME</given-names></name></person-group><article-title>Dexmedetomidine versus midazolam in outpatient third molar surgery</article-title><source>J Oral Maxillofac Surg</source><year>2006</year><volume>64</volume><fpage>1353</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16916668</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Uhrich</surname><given-names>TD</given-names></name><name><surname>Barney</surname><given-names>JA</given-names></name><name><surname>Arain</surname><given-names>SR</given-names></name><name><surname>Ebert</surname><given-names>TJ</given-names></name></person-group><article-title>Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions</article-title><source>Anesth Analg</source><year>2000</year><volume>90</volume><fpage>699</fpage><lpage>705</lpage><pub-id pub-id-type="pmid">10702460</pub-id></element-citation></ref></ref-list></back></article>